ANNA ESTER GARINO

Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Acute Care NEW YORK, NY NPI 1063137362

General Payments — all program years on this page

$3,451.16

  • Category: General Payments
  • Program years: PY2023–2024
  • Record count: 61
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $2,625.48 across 39 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $1,343.9932
Travel and Lodging $756.495
Consulting Fee $525.002

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2023 $825.6822
2024 $2,625.4839

Records — PY2024 (39)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1080566033 ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $24.18 08/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1081722487 Lexicon Pharmaceuticals, Inc. $21.87 06/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1081722489 Lexicon Pharmaceuticals, Inc. $24.53 05/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087426242 Novartis Pharmaceuticals Corporation $23.97 03/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087426246 Novartis Pharmaceuticals Corporation $15.39 03/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087426266 Novartis Pharmaceuticals Corporation $21.59 10/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100399823 Impulse Dynamics (USA) Inc. $49.09 07/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100399827 Impulse Dynamics (USA) Inc. $52.11 02/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104433965 AstraZeneca Pharmaceuticals LP $20.45 08/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104551572 AstraZeneca Pharmaceuticals LP $22.48 12/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104625866 AstraZeneca Pharmaceuticals LP $2.31 07/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104642499 AstraZeneca Pharmaceuticals LP $16.01 03/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104729491 AstraZeneca Pharmaceuticals LP $23.69 11/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105426984 AstraZeneca Pharmaceuticals LP $23.86 03/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105544463 AstraZeneca Pharmaceuticals LP $26.40 07/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105596591 AstraZeneca Pharmaceuticals LP $22.61 06/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1124818857 Abbott Laboratories $137.14 01/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1124818860 Abbott Laboratories $117.58 05/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1124818865 Abbott Laboratories $79.47 06/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1124818869 Abbott Laboratories $41.50 06/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1124818873 Abbott Laboratories $130.65 08/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1124818877 Abbott Laboratories $150.00 09/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1124818881 Abbott Laboratories $13.64 12/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1124818885 Abbott Laboratories $39.21 04/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1124818889 Abbott Laboratories $90.59 04/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1125386216 Abbott Laboratories $350.00 04/30/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1125386218 Abbott Laboratories $279.10 06/04/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1125386220 Abbott Laboratories $45.08 06/04/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1125386222 Abbott Laboratories $48.30 07/23/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1125386224 Abbott Laboratories $374.99 07/23/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1125386226 Abbott Laboratories $175.00 12/24/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1125386228 Abbott Laboratories $9.02 06/04/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1125822937 Alnylam Pharmaceuticals Inc. $22.47 09/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131200247 PFIZER INC. $16.55 02/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131205241 PFIZER INC. $16.99 11/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141735617 Merck Sharp & Dohme LLC $22.80 01/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141881688 Merck Sharp & Dohme LLC $18.13 08/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141938623 Merck Sharp & Dohme LLC $22.49 06/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1146921808 Philips North America LLC $34.24 09/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.